Columbus S. Mavhunga is a multimedia journalist based in Harare, the capital of Zimbabwe.
A month into its COVID-19 vaccine rollout, Zimbabwe has struggled to surpass the 75,000 mark as some front-line health workers are skeptical about the Chinese-made Sinopharm efficacy rate.